Gilead.com

Gilead Sciences, Inc. is a biopharmaceutical company that discovers, develops, and commercializes innovative medicines in areas of unmet medical need. Founded in 1987, Gilead has a strong commitment to advancing the care of patients with life-threatening diseases.

The company’s primary focus is on antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza. Gilead is also dedicated to developing therapies for cancer, inflammatory diseases, and other serious conditions.

Core Values

• Innovation: Gilead invests heavily in research and development to bring new therapies to market.
• Patient-Centricity: The company prioritizes the needs of patients and strives to improve their quality of life.
• Collaboration: Gilead works with healthcare professionals, researchers, and patient advocacy groups to enhance treatment options.

With a global presence, Gilead operates in more than 35 countries and has a diverse workforce dedicated to making a difference in the lives of patients. The company’s headquarters are located in Foster City, California, but it has significant operations in the UK.

Gilead is committed to corporate social responsibility, focusing on access to medicines, sustainability, and community engagement. Through various initiatives, the company aims to ensure that its innovative therapies reach those who need them most.

As a leader in the biopharmaceutical industry, Gilead continues to push the boundaries of science and medicine, striving to create a healthier world for all.